Reports

Brasil-China Pós-Covid-19: Pesquisa Científica e Biotecnologia

  • Asia
  • 14 august 2020

In the context of the global race to develop vaccines against COVID-19, Brazilian and Chinese experts discuss cooperation possibilities between the two countries. The report presents the topics discussed in the webinar "Brazil-China Post Covid-19: Scientific Research and Biotechnology", conducted by CEBRI in partnership with the Embassy of China. Carlos Morel states "When I saw a room with 150 people, working morning, afternoon and night, I was really impacted and thought we had to partner up with the Chinese institutions". Yuntao Zhang says "It is the moment with the largest number of vaccines against a single virus in human history."

Only available in Portuguese.

In the context of the global race to develop vaccines against COVID-19, Brazilian and Chinese experts discuss cooperation possibilities between the two countries. The report presents the topics discussed in the webinar "Brazil-China Post Covid-19: Scientific Research and Biotechnology", conducted by CEBRI in partnership with the Embassy of China. Carlos Morel states "When I saw a room with 150 people, working morning, afternoon and night, I was really impacted and thought we had to partner up with the Chinese institutions". Yuntao Zhang says "It is the moment with the largest number of vaccines against a single virus in human history."

Only available in Portuguese.

Participants in this publication

Marcos Caramuru
International Advisory Board

Former Ambassador of Brazil to the People's Republic of China

Carlos Morel
Coordinator of the Technological Development Center at Fiocruz

Luiz Davidovich
President of the Brazilian Academy of Sciences (ABC)

Margareth Dalcolmo
Physician and Researcher at Fiocruz

Qu Yuhui
Minister Counsellor at the Chinese Embassy in Brazil

MORE FROM THE PROGRAM

RELATED TOPICS